Nervonik
Healthcare · Biotech
Nervonik Secures $52.5M Series B for Nerve Stimulation Tech
April 27, 2026$53M · Series B
Nervonik closed an oversubscribed $52.5 million Series B round led by Amzak Health to advance its peripheral nerve stimulation system. Funds will drive development and commercialization of the clinical-stage technology.
Lead Investors
Amzak Health
Read the Full Story in Velocity
Get curated startup and tech news with new stories published daily, company insights, and real-time alerts.